Fezolinetant offers a non-hormonal option for managing moderate to severe vasomotor symptoms, commonly known as hot flashes and night sweats, linked to menopause. By targeting neurokinin B receptors in the brain, it helps regulate body temperature. This medication primarily benefits postmenopausal individuals seeking relief from these disruptive symptoms without using hormones.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends